276 related articles for article (PubMed ID: 27126073)
1. EF-Tu from the enacyloxin producing Frateuria W-315 strain: Structure/activity relationship and antibiotic resistance.
Créchet JB; Malosse C; Hountondji C
Biochimie; 2016 Aug; 127():59-69. PubMed ID: 27126073
[TBL] [Abstract][Full Text] [Related]
2. Mutant EF-Tu species reveal novel features of the enacyloxin IIa inhibition mechanism on the ribosome.
Zuurmond AM; Olsthoorn-Tieleman LN; Martien de Graaf J; Parmeggiani A; Kraal B
J Mol Biol; 1999 Dec; 294(3):627-37. PubMed ID: 10610785
[TBL] [Abstract][Full Text] [Related]
3. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
Cetin R; Anborgh PH; Cool RH; Parmeggiani A
Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
[TBL] [Abstract][Full Text] [Related]
4. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
[TBL] [Abstract][Full Text] [Related]
5. Effects of mutagenesis of Gln97 in the switch II region of Escherichia coli elongation factor Tu on its interaction with guanine nucleotides, elongation factor Ts, and aminoacyl-tRNA.
Navratil T; Spremulli LL
Biochemistry; 2003 Nov; 42(46):13587-95. PubMed ID: 14622005
[TBL] [Abstract][Full Text] [Related]
6. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
Anborgh PH; Okamura S; Parmeggiani A
Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
[TBL] [Abstract][Full Text] [Related]
7. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
[TBL] [Abstract][Full Text] [Related]
8. Substitution of Arg230 and Arg233 in Escherichia coli elongation factor Tu strongly enhances its pulvomycin resistance.
Boon K; Krab I; Parmeggiani A; Bosch L; Kraal B
Eur J Biochem; 1995 Feb; 227(3):816-22. PubMed ID: 7867642
[TBL] [Abstract][Full Text] [Related]
9. Relevance of histidine-84 in the elongation factor Tu GTPase activity and in poly(Phe) synthesis: its substitution by glutamine and alanine.
Scarano G; Krab IM; Bocchini V; Parmeggiani A
FEBS Lett; 1995 May; 365(2-3):214-8. PubMed ID: 7781781
[TBL] [Abstract][Full Text] [Related]
10. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
Fasano O; Parmeggiani A
Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
[TBL] [Abstract][Full Text] [Related]
11. Limited proteolysis and amino acid replacements in the effector region of Thermus thermophilus elongation factor Tu.
Zeidler W; Schirmer NK; Egle C; Ribeiro S; Kreutzer R; Sprinzl M
Eur J Biochem; 1996 Jul; 239(2):265-71. PubMed ID: 8706729
[TBL] [Abstract][Full Text] [Related]
12. Probing the reactivity of the GTP- and GDP-bound conformations of elongation factor Tu in complex with the antibiotic GE2270 A.
Anborgh PH; Parmeggiani A
J Biol Chem; 1993 Nov; 268(33):24622-8. PubMed ID: 8227020
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis of glutamine 290 in Escherichia coli and mitochondrial elongation factor Tu affects interactions with mitochondrial aminoacyl-tRNAs and GTPase activity.
Hunter SE; Spremulli LL
Biochemistry; 2004 Jun; 43(22):6917-27. PubMed ID: 15170329
[TBL] [Abstract][Full Text] [Related]
14. The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.
Mesters JR; Zeef LA; Hilgenfeld R; de Graaf JM; Kraal B; Bosch L
EMBO J; 1994 Oct; 13(20):4877-85. PubMed ID: 7525272
[TBL] [Abstract][Full Text] [Related]
15. Properties of isolated domains of the elongation factor Tu from Thermus thermophilus HB8.
Nock S; Grillenbeck N; Ahmadian MR; Ribeiro S; Kreutzer R; Sprinzl M
Eur J Biochem; 1995 Nov; 234(1):132-9. PubMed ID: 8529632
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of three residues, isoleucine-60, threonine-61, and aspartic acid-80, implicated in the GTPase activity of Escherichia coli elongation factor Tu.
Krab IM; Parmeggiani A
Biochemistry; 1999 Oct; 38(40):13035-41. PubMed ID: 10529173
[TBL] [Abstract][Full Text] [Related]
17. Mutations to kirromycin resistance occur in the interface of domains I and III of EF-Tu.GTP.
Abdulkarim F; Liljas L; Hughes D
FEBS Lett; 1994 Sep; 352(2):118-22. PubMed ID: 7925958
[TBL] [Abstract][Full Text] [Related]
18. Enacyloxin IIa pinpoints a binding pocket of elongation factor Tu for development of novel antibiotics.
Parmeggiani A; Krab IM; Watanabe T; Nielsen RC; Dahlberg C; Nyborg J; Nissen P
J Biol Chem; 2006 Feb; 281(5):2893-900. PubMed ID: 16257965
[TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis of elongation factor Tu. The functional and structural role of residue Cys81.
Anborgh PH; Parmeggiani A; Jonák J
Eur J Biochem; 1992 Sep; 208(2):251-7. PubMed ID: 1521523
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationships of elongation factor Tu. Isolation and activity of the guanine-nucleotide-binding domain.
Jensen M; Cool RH; Mortensen KK; Clark BF; Parmeggiani A
Eur J Biochem; 1989 Jun; 182(2):247-55. PubMed ID: 2661226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
